Invesco Ltd. (IVZ) — Fair Value Analysis

Base-case fair value (P50): $35.61 · Current price: $32.55 · Verdict: Fairly Valued

The Verdict on IVZ

Based on our Monte Carlo simulations, Invesco (IVZ) is currently Fairly Valued. The analysis indicates that IVZ's current price of $32.55 sits reasonably close to its median fair value (P50) of $35.61. While this suggests a potential +9.4% upside to our P50 target, the overall verdict points to a stock that is neither significantly overvalued nor undervalued at this juncture. This assessment considers IVZ's operational and financial health, which our models rate as "weak" relative to its Financial Services sector peers.

How IVZ stacks up against Financial Services

Invesco's "weak" quality tier is a critical factor in its Fairly Valued assessment. This classification reflects a comparative view of its operational and financial health within the demanding Financial Services sector. While the median fair value of $35.61 implies some headroom from the current $32.55, this weaker health profile suggests inherent limitations or risks that cap a more aggressive valuation. For investors evaluating IVZ, its relative positioning in the sector, defined by this quality tier, grounds the Monte Carlo-derived fair value.

What this means for investors

Investors considering IVZ should interpret the Fairly Valued verdict in conjunction with its "weak" quality tier. The slight +9.4% from $32.55 to the $35.61 median fair value indicates the market is pricing Invesco efficiently, given its current fundamentals and sector standing. While not overvalued, the weak quality tier suggests that significant outperformance without fundamental improvements might be challenging, even if the stock isn't trading at a premium. For a complete picture, FairCurve subscribers can access the full Monte Carlo distribution, including bear (P10) and bull (P90) case targets. Sign up for FairCurve to see the full bear/bull distribution and track IVZ's fair value as new fundamentals are released.